Noticias de EXAS_US

Noticias del mercado

Últimas noticias sobre EXAS_US — 78 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: EXAS_US ✕ 78 resultados
17/04/2026 EXAS_US — Stock Titan ES ← EN
Abbott dice que un análisis de sangre con dos biomarcadores mejora la detección temprana del cáncer
17/04/2026 EXAS_US — Abbott MediaRoom
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
17/04/2026 EXAS_US — PR Newswire
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
16/04/2026 EXAS_US — Reuters
Exact Sciences Corporation
02/04/2026 EXAS_US — Stock Titan
Exact Sciences (NASDAQ: EXAS) files Form 15 to suspend certain SEC reporting duties
28/03/2026 EXAS_US — MarketBeat
Wealth Enhancement Advisory Services LLC Buys 18,415 Shares of Exact Sciences Corporation $EXAS
24/03/2026 EXAS_US — MEXC
Abbott (ABT) Finalizes $21 Billion Exact Sciences (EXAS) Takeover
24/03/2026 EXAS_US — MarketScreener
Exact Sciences Corporation(NasdaqCM: EXAS) dropped from S&P TMI Index
24/03/2026 EXAS_US — MarketScreener
Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Biotechnology Select Industry Index
24/03/2026 EXAS_US — MarketScreener
Exact Sciences Corporation(NasdaqCM: EXAS) dropped from S&P Global BMI Index
23/03/2026 EXAS_US — Stock Titan
Exact Sciences (EXAS) director has equity cancelled and cashed out at $105 per share in Abbott merger
23/03/2026 EXAS_US — Stock Titan
Merger cashes out Exact Sciences (EXAS) director’s shares at $105
23/03/2026 EXAS_US — Stock Titan
Abbott deal converts Exact Sciences (EXAS) GC Herriott’s stock, options and RSUs
23/03/2026 EXAS_US — Investing.com
Abbott completes $21 billion acquisition of Exact Sciences, delisting EXAS from Nasdaq
23/03/2026 EXAS_US — Stock Titan
Abbott (NYSE: ABT) closes Exact Sciences cancer diagnostics deal
23/03/2026 EXAS_US — Stock Titan
Abbott buys Exact Sciences (NASDAQ: EXAS) in $21B cash deal
23/03/2026 EXAS_US — Stock Titan
Executive equity overhauled as Exact Sciences (EXAS) completes Abbott cash merger
23/03/2026 EXAS_US — Stock Titan
Abbott buys Exact Sciences (NASDAQ: EXAS) in $105-per-share cash merger
23/03/2026 EXAS_US — Stock Titan
Abbott acquires Exact Sciences (NASDAQ: EXAS) in $105-per-share cash deal
23/03/2026 EXAS_US — Stock Titan
Abbott deal: Exact Sciences (EXAS) CEO equity cashed out or converted

Página 2 de 4

keyboard_arrow_up